Recruiting studies: Donor Lymphocyte Infusion

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Blinatumomab Combined With Low-dose DLI as Maintenance Therapy After Transplantation for B-ALL
Phase 1 · 1 location(s) · Liping Dou · NCT07677878 CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT
Phase 3 · 1 location(s) · Peking University People's Hospital · NCT07441291 CD45RA Depleted DLI After TCRα/β Depleted Haploidentical HCT
Phase 1/Phase 2 · 2 location(s) · University Hospital Tuebingen · NCT05943067 Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus H
Phase 2/Phase 3 · 1 location(s) · Federal Research Institute of Pediatric Hematology, Oncology · NCT07366801 Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Pati
NA · 1 location(s) · University of Wisconsin, Madison · NCT07285668 Phase I Study of CTL Anti-DP Infusion Post-hematopoietic Stem Cell Transplantation
Phase 1 · 1 location(s) · Nantes University Hospital · NCT04180059 Innate Donor Effector Allogeneic Lymphocyte Infusion After Stem Cell Transplantation: the IDEAL Trial
Phase 2/Phase 3 · 1 location(s) · Rigshospitalet, Denmark · NCT05686538 VMAC+DLI Treatment of Patients With Relapse of AML After Allo-HSCT
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06447090 CD62L Depleted Donor Lymphocyte Infusion With T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation
Phase 2 · 1 location(s) · Hong Kong Children's Hospital · NCT06034535 Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoi
Phase 2 · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT07105579 Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05327023 Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation
Phase 4 · 1 location(s) · Suping ZHANG · NCT06339775 Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome
Phase 2 · 3 location(s) · Sawa Ito, MD · NCT06529731 Prophylactic CD45RA-depleted DLI After Haploidentical Transplantation/RIC
Phase 1 · 1 location(s) · University Hospital, Geneva · NCT05066412 Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
EARLY_Phase 1 · 1 location(s) · University of Arizona · NCT06643221

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.